Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Richard Baker / In Pictures via Getty Images

68 people have died from a lung injury associated with e-cigarette use in 29 states and the District of Columbia, the Centers for Disease Control and Prevention reports as of Feb. 18.

What's new: Because of the consistent declines in new EVALI cases since Sept. 2019, as well as the identification of vitamin E acetate as a primary cause of EVALI, Tuesday's report will be the final CDC update on the number of hospitalized EVALI cases and deaths nationally.

CDC explains the steady drop in cases as likely multifactorial and possibly related to:

  • Public awareness of the risk associated with THC-containing e-cigarettes, vaping and product use.
  • The elimination of vitamin E acetate from some products.
  • Law enforcement response related to illicit products.

Details: CDC, FDA and individual state health officials "have made progress in identifying the cause of EVALI," CDC reports.

  • Nationally, most vaping-related patients with data on how they sourced products reported obtaining THC-containing products from "informal sources," per the CDC. The agency recommends users should consider no longer vaping THC products, rather than its original claim to refrain from e-cigarettes.
  • Vitamin E acetate has been found in product samples tested by FDA and state labs and patient lung fluid samples tested by CDC across the country.
  • Vitamin E acetate is not present in the lung fluid of those who do not have EVALI.
  • Based on several studies, federal health officials found in late 2019 vitamin E acetate in a sample of illicit products in select states and the additive also caused lung fluid in 48 patients out of 51 diagnosed with the vaping illness.

By the numbers: Data as of Feb. 18 showed the median age of patients who died was 49.5 years old and the ages of those who died ranged from 15 to 75.

The impact: The CDC and states' individual health departments have data on where EVALI-related deaths occurred:

  • The Henry Ford Hospital in Detroit announced in mid-November that a 17-year-old boy faced "imminent death" from vaping injuries unless he underwent a double lung transplant. It was the first transplant performed on a patient with the vaping-related illness.
  • In New York, the first teenager died after being hospitalized twice in September with a vaping-related illness.
  • In Massachusetts, the death of a woman in her 60s was reported on Oct. 7 as the state's first vaping-related death. The state currently has a four-month ban on all vaping products, the harshest in the U.S.
  • In Georgia, a patient with a history of heavy nicotine vaping, but no reported background of vaping THC, died, Georgia's Department of Health said.
  • A man and woman in Kansas, both over the age of 50 with "underlying health conditions," died from a pulmonary illness linked to vaping, according to Kansas Gov. Laura Kelly.
  • A Missouri man in his mid-40s died from the illness, according to the state's Department of Health and Senior Services.

The big picture: The CDC reported 2,807 confirmed hospital cases of severe respiratory illnesses as of Feb. 18, among those who vaped nicotine or cannabis products in 50 states, D.C. and two U.S. territories.

  • The rate of reported cases each week has slowed considerably since August.

Go deeper:

Go deeper

Latino mental health crisis grows

Shoshana Gordon/Axios

Over 40% of Latino adults have reported symptoms of depression during the pandemic, in contrast to 25% of white non-Hispanics, the CDC reports.

Why it matters: The emotional distress is especially acute for Latinos who had COVID-19, some of them tell Noticias Telemundo.

Misinformation is just one part of a vaccine trust problem

Illustration: Sarah Grillo/Axios

COVID-19 is the first major pandemic in the social media era — offering experts a rare opening to study the relationship between online misinformation and human behavior on a large scale.

Why it matters: As misinformation about COVID-19 vaccines runs rampant, researchers are trying to measure how much memes and messages with false information can alter someone's decision to get vaccinated.

2 hours ago - World

Israel's "change bloc" collapses, leaving Netanyahu in charge

Bennett (L) with Netanyahu in 2015. Photo: Gali Tibbon/AFP via Getty Images

In a dramatic shift that comes amid fighting in the Gaza strip and clashes between Jewish and Arab citizens in Israel, right-wing kingmaker Naftali Bennett has announced he will no longer seek an alternative government to oust Prime Minister Benjamin Netanyahu.

Why it matters: Bennett had been on the verge of a power-sharing deal with centrist opposition leader Yair Lapid that would have made him prime minister for two years until Lapid rotated into the job. Without Bennett, Lapid has no path to a majority, and Israel will almost certainly head for its fifth election since 2019 with Netanyahu still in his post.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!